A limited capacity for microglial repopulation in the adult brain
Open accessAbstract
Microglia are the resident immune cell of the central nervous system (CNS), and serve to protect and maintain the local brain environment. Microglia are critically dependent on signaling through the colony‐stimulating factor 1 receptor (CSF1R); administration of CSF1R inhibitors that cross the blood brain barrier (BBB) lead to the elimination of up to 99% of microglia, depending on CNS exposure and treatment duration. Once microglia are depleted, withdrawal of inhibitor stimulates repopulation of the entire CNS with new cells, conceivably enabling a therapeutic strategy for beneficial renewal of the entire microglial tissue. We have explored the kinetics and limits of this repopulation event and show that the rate of microglial repopulation is proportional to the extent of microglial depletion – greater depletion of microglia results in more rapid repopulation. Using a CSF1R inhibitor formulation that eliminates approximately 99% of microglia within 7 days, we subjected mice to multiple rounds of elimination (7 days’ treatment) and repopulation (7 days’ recovery) and found that the brain only has the capacity for a single complete repopulation event; subsequent elimination and CSF1R inhibitor withdrawal fail to repopulate the brain. However, if the recovery time between, or after, cycles is extended sufficiently then the brain can ultimately repopulate. These kinetic studies define the opportunities and possible limits of the remarkable renewal capacities of microglia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CSF1Ri treatment in non-transgenic mice induced the expected loss of microglial gene signature from the brain transcriptome.
“As before (Najafi et al. , 2018), CSF1Ri treatment in non-transgenic mice induced the expected loss of microglial gene signature from the brain transcriptome (data not shown).”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Najafi et al., 2018
PLX3397 formulated at 600 ppm in chow achieves robust brain-wide microglial elimination (>99%).
“We established that PLX3397 formulated at 600 ppm in chow could achieve robust brain-wide microglial elimination ( > 99%)38, and thus, treated 1.5-month-old 5xFAD mice with this formulation until 5 months of age (Fig. 7a).”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 49 · Cited by 99
- Authors
- Najafi, A. R., Crapser, J., Jiang, S., Ng, W., Mortazavi, A., West, B. L., & Green, K. N.
- Affiliations
- University of California, Irvine (US)
- Plexxikon (United States) (US)
- Corresponding author
- Green, Kim N.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2018-10-28
- Volume
- 66
- Issue
- 11
- Pages
- 2385-2396
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- PMC
- PMC6269202
- OpenAlex
- W2899174889
- Cited by
- 99
- References
- 49
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 8 · 2023: 13 · 2022: 11 · 2021: 17 · 2020: 15 · 2019: 8
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Glia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (AG00096, AG016573, P50, R01NS083801)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- microglia, microglial repopulation, CSF1R inhibition, colony-stimulating factor 1 receptor, microglial depletion, blood-brain barrier, microglial homeostasis
- MeSH terms
- CX3C Chemokine Receptor 1, Aminopyridines, Animals, Brain, Calcium-Binding Proteins, Dose-Response Relationship, Drug, Glial Fibrillary Acidic Protein, Luminescent Proteins, Male, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Pyrroles, Signal Transduction, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Microglia, Receptor, Platelet-Derived Growth Factor alpha, Gene Expression Profiling, Mice, Gene Ontology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review